← FDA DRUG APPROVALS

FDA ANDA · ANDA073079

LOPERAMIDE HYDROCHLORIDE

Sponsor: ALLIED

APPLICATION
ANDA073079
TYPE
ANDA
ORIGINAL APPROVAL
1992-04-30
LATEST ACTION
1998-10-14
ROUTE
ORAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued

Products

LOPERAMIDE HYDROCHLORIDEDiscontinued
LOPERAMIDE HYDROCHLORIDE 1MG/5ML · SOLUTION · ORAL

Approval history

1998-10-14Manufacturing (CMC) · Supplement 7AP
1998-03-09Labeling · Supplement 5AP
1996-08-28Manufacturing (CMC) · Supplement 4AP
1993-03-29Labeling · Supplement 2AP
1993-03-29Manufacturing (CMC) · Supplement 1AP
1992-04-30OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →